Yonsei Medical Journal

Yonsei Univ College Medicine (연세대학교의과대학)
권호 표지
DOI QR코드

DOI QR Code

Change of Antimicrobial Susceptibility among Escherichia coli Strains Isolated from Female Patients with Community-Onset Acute Pyelonephritis

  • Lim, Seung-Kwan (Department of Infectious Diseases, Ajou University School of Medicine) ;
  • Park, In Whee (Department of Nephrology Medicine, Ajou University School of Medicine) ;
  • Lee, Wee Gyo (Department of Laboratory Medicine, Ajou University School of Medicine) ;
  • Kim, Hyun Kyung (Department of Infectious Diseases, Ajou University School of Medicine) ;
  • Choi, Young Hwa (Department of Infectious Diseases, Ajou University School of Medicine)
  • Published : 2012.02.01
⟨ Previous Next ⟩

Abstract

Purpose: There is a concern on which antimicrobials are appropriate as empirical agents for community-onset acute pyelonephritis (APN) in regions where the fluoroquinolone resistance rate is high, such as in Korea. Materials and Methods: Three hundred and two strains of E. coli in 2001-2002 and 349 strains in 2008-2009 were isolated from the urine cultures of female adult APN patients, and the antimicrobial susceptibility was compared according to each study period. All the patients were classified as uncomplicated or complicated APN, and a subgroup analysis was done thereafter. Results: The E. coli strains isolated in 2008-2009 showed improved susceptibility to trimethoprim-sulfamethoxazole compared to those isolated in 2001-2002. However, the third generation cephalosporin and gentamicin susceptibility was worsened. Of the 232 isolates from the uncomplicated APN patients, there was no difference between the two different time periods. On the other hand, of the 419 isolates from the complicated APN patients, the susceptibility to third generation cephalosporin, gentamicin and ciprofloxacin was significantly worsened. Conclusion: The antimicrobial susceptibility of E. coli changed over the study period, however, this change occurred mainly in the complicated APN patients. In Korea, ciprofloxacin is still useful as an empirical agent for uncomplicated APN patients, but this is not the case for patients with complicated APN because of high resistance rate to ciprofloxacin in these patients. For the complicated APN patients, the rate of resistance to ciprofloxacin is already more than 30%.

Keywords

References

  1. Foxman B, Klemstine KL, Brown PD. Acute pyelonephritis in US hospitals in 1997: hospitalization and in-hospital mortality. Ann Epidemiol 2003;13:144-50. https://doi.org/10.1016/S1047-2797(02)00272-7
  2. Tenner SM, Yadven MW, Kimmel PL. Acute pyelonephritis. Preventing complications through prompt diagnosis and proper therapy. Postgrad Med 1992;91:261-8.
  3. Ramakrishnan K, Scheid DC. Diagnosis and management of acute pyelonephritis in adults. Am Fam Physician 2005;71:933-42.
  4. Stamm WE. Urinary tract infection, pyelonephritis, and prostatitis. In: Harrison TR, Braunwald E, editors. Harrison's principles of internal medicine. 17 ed. New York: McGraw-Hill; 2008. p.1820-7.
  5. Gupta K, Hooton TM, Stamm WE. Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections. Ann Intern Med 2001;135:41-50. https://doi.org/10.7326/0003-4819-135-1-200107030-00012
  6. Stamm WE, Hooton TM. Management of urinary tract infections in adults. N Engl J Med 1993;329:1328-34. https://doi.org/10.1056/NEJM199310283291808
  7. Wie SH, Chang UI, Kim HW, Kim YS, Kim SY, Hur J, et al. Clinical features and antimicrobial resistance among clinical isolates of women with community-acquired acute pyelonephritis in 2001-2006. Infect Chemother 2007;39:9-16.
  8. Kim KY, Kim CS, Lim DH. The ciprofloxacin resistance pattern of escherichia coli isolated from female patients with community- acquired urinary tract infection in the Jeonnam and Gwangju region for the recent 2-years. Korean J Urol 2008;49:540-8. https://doi.org/10.4111/kju.2008.49.6.540
  9. Hwang BY, Lee JG, Park DW, Lee YJ, Kim SB, Eom JS, et al. Antimicrobial susceptibility of causative microorganisms in adults with acute pyelonephritis at one university-affiliated hospital in southwestern Seoul. Infect Chemother 2003;35:277-82.
  10. Kim JH, Lee CS, Choi NW, Park SK, Lee CH, Kim G, et al. Quinolone resistance in community-acquired acute pyelonephritis. Korean J Nephrol 2006;25:571-8.
  11. Kim YR, Huh JS, Kang SH. Patterns of antimicrobial susceptibility of the causative bacteria of urinary tract infections in recent years in an island region. Korean J Clin Microbiol 2007;10:19-24.
  12. Jeong KY, Park JO, Kim DK, Kwak YH. Treatment of acute pyelonephritis in emergency department; comparison of the efficacy of ciprofloxacin and 3rd generation cephalosporin. Infect Chemother 2007;39:296-303.
  13. Kim YJ, Lee SH, Kang YN, Kim WC, Kim SI, Wie SH, et al. The trend of antibiotic production in Korea during 1981-2003. Infect Chemother 2005;37:271-9.
  14. Goettsch W, van Pelt W, Nagelkerke N, Hendrix MG, Buiting AG, Petit PL, et al. Increasing resistance to fluoroquinolones in escherichia coli from urinary tract infections in the Netherlands. J Antimicrob Chemother 2000;46:223-8. https://doi.org/10.1093/jac/46.2.223
  15. American Thoracic Society; Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005;171:388-416. https://doi.org/10.1164/rccm.200405-644ST
  16. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008;36:309-32. https://doi.org/10.1016/j.ajic.2008.03.002
  17. Nicolle LE. A practical guide to the management of complicated urinary tract infection. Drugs 1997;53:583-92. https://doi.org/10.2165/00003495-199753040-00004
  18. McGregor JC, Allen GP, Bearden DT. Levofloxacin in the treatment of complicated urinary tract infections and acute pyelonephritis. Ther Clin Risk Manag 2008;4:843-53. https://doi.org/10.2147/TCRM.S3426
  19. Ronald AR, Harding GK. Complicated urinary tract infections. Infect Dis Clin North Am 1997;11:583-92. https://doi.org/10.1016/S0891-5520(05)70374-3
  20. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. 18th international supplement M100-S18. Document M7-A7, Wayne, PA: Clinical and Laboratory Standards Institute; 2008.
  21. Robin F, Delmas J, Schweitzer C, Bonnet R. Evaluation of the Vitek-2 extended-spectrum beta-lactamase test against non-duplicate strains of Enterobacteriaceae producing a broad diversity of well-characterised beta-lactamases. Clin Microbiol Infect 2008;14:148-54. https://doi.org/10.1111/j.1469-0691.2007.01893.x
  22. Kahlmeter G; ECO.SENS. An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: the ECO.SENS Project. J Antimicrob Chemother 2003;51:69-76. https://doi.org/10.1093/jac/dkg028
  23. Rodriguez-Bano J, Paterson DL. A change in the epidemiology of infections due to extended-spectrum beta-lactamase-producing organisms. Clin Infect Dis 2006;42:935-7. https://doi.org/10.1086/500945
  24. Talan DA, Krishnadasan A, Abrahamian FM, Stamm WE, Moran GJ; EMERGEncy ID NET Study Group. Prevalence and risk factor analysis of trimethoprim-sulfamethoxazole- and fluoroquinolone-resistant Escherichia coli infection among emergency department patients with pyelonephritis. Clin Infect Dis 2008;47:1150-8. https://doi.org/10.1086/592250
  25. Gupta K, Scholes D, Stamm WE. Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women. JAMA 1999;281:736-8. https://doi.org/10.1001/jama.281.8.736
  26. Warren JW, Abrutyn E, Hebel JR, Johnson JR, Schaeffer AJ, Stamm WE. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA). Clin Infect Dis 1999;29:745-58. https://doi.org/10.1086/520427
  27. Lee JM, Hwang KW, Jegal S. Antimicrobial resistance in Escherichia coli isolated from healthy volunteers of the community. Korean J Clin Microbiol 2007;10:32-6.
  28. Czaja CA, Scholes D, Hooton TM, Stamm WE. Population-based epidemiologic analysis of acute pyelonephritis. Clin Infect Dis 2007;45:273-80. https://doi.org/10.1086/519268
  29. Lee JS, Rho SH, Kim SE, Nam TM, Kim JS, Kim SG, et al. A study on the clinical and microbiologic features of community-acquired acute pyelonephritis for the recent 5 years in a university hospital. Korean J Nephrol 2002;21:905-13.

Cited by

  1. Global Fluoroquinolone Resistance Epidemiology and Implictions for Clinical Use vol.2012, pp.None, 2012, https://doi.org/10.1155/2012/976273
  2. The Choice of Empirical Treatment of Uncomplicated Cystitis: No Longer Free Ride vol.44, pp.4, 2012, https://doi.org/10.3947/ic.2012.44.4.323
  3. Bacteriology, Antibiotic Susceptibility and Empirical Antibiotics of Community-acquired Perforated Appendicitis vol.44, pp.6, 2012, https://doi.org/10.3947/ic.2012.44.6.439
  4. Use of Gentamicin for Women with Community-Acquired Uncomplicated Acute Pyelonephritis Caused by Gentamicin-Susceptible or -ResistantEscherichia coli:10-Year Experience vol.19, pp.4, 2012, https://doi.org/10.1089/mdr.2012.0140
  5. L-glutamine:D-fructose-6-phosphate Aminotransferase as a Key Protein Linked to Multidrug Resistance in E. coli KD43162 vol.58, pp.3, 2012, https://doi.org/10.3839/jabc.2015.035
  6. A comparison of the clinical characteristics of elderly and non-elderly women with community-onset, non-obstructive acute pyelonephritis vol.30, pp.3, 2015, https://doi.org/10.3904/kjim.2015.30.3.372
  7. Comparison of Second- and Third-Generation Cephalosporin as Initial Therapy for Women with Community-Onset Uncomplicated Acute Pyelonephritis vol.56, pp.5, 2015, https://doi.org/10.3349/ymj.2015.56.5.1266
  8. Use of cefuroxime for women with community-onset acute pyelonephritis caused by cefuroxime-susceptible or -resistant Escherichia coli vol.31, pp.1, 2012, https://doi.org/10.3904/kjim.2016.31.1.145
  9. Prevalence of antibiotic susceptibility and resistance of Escherichia coli in acute uncomplicated cystitis in Korea : Systematic review and meta-analysis vol.95, pp.36, 2012, https://doi.org/10.1097/md.0000000000004663
  10. Characterization of Ciprofloxacin Permeation Pathways across the Porin OmpC Using Metadynamics and a String Method vol.13, pp.9, 2017, https://doi.org/10.1021/acs.jctc.7b00467
  11. Enrofloxacin Permeation Pathways across the Porin OmpC vol.122, pp.4, 2012, https://doi.org/10.1021/acs.jpcb.7b12568